drugset / Trial / NCT02656485

A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris

NCT02656485 ↗

Phase 1/2 Completed 36 enrolled AOBiome LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a single center, randomized, double-blind, placebo-controlled study in subjects with acne vulgaris.

Timeline

Start
2015-08-05
Primary completion
2016-03-01
Completion
2016-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject B244 Other / unclassified 2e+10 unknown Topical
Subject B244 Other / unclassified 4e+10 unknown Topical
Subject B244 Other / unclassified 8e+10 unknown Topical

Indications